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INTRODUCTION
Hepatocellular carcinoma (HCC) is the fifth most common tumor in the world, and the incidence of HCC has been increasing rapidly, especially in western countries (1, 2) . Imaging diagnosis is essential for planning the treatment and management of HCC. Contrast-enhanced ultrasound, contrast-enhanced computed tomography (CT), and magnetic resonance imaging (MRI) have made it possible to accurately detect and characterize HCC (3) (4) (5) . MRI is particularly useful due to its high tissue contrast and the availability of tissue-specific contrast agents.
Various liver-specific MRI contrast agents have been introduced to increase the accuracy of hepatic imaging (6) (7) (8) . Gadoxetic acid (Eovist or Primovist, Bayer Schering: Berlin, Germany) has been approved for hepatic imaging and is being widely used (9) (10) (11) (12) . It is a liver-specific hepatobiliary contrast agent which can also be used extracellularly. It is taken up by functioning hepatocytes and up to 50% is excreted into the bile (9, 13) . There have ) and dynamic gadoxetic acid-enhanced MRI as well as hepatobiliary phase were performed. Images were retrospectively reviewed by two radiologists to compare the diagnostic performances of DWI and Gdx MRI alone and in combination for the detection of HCC. Alternative free response receiver operating characteristic analysis and comparison of sensitivities were used for statistical analysis. Results: The sensitivity of Gdx set (73/84, 87%) was significantly higher than that of DWI set (60.5/84, 72%) for both observers. The Az values of DWI and Gdx MRI for the detection of HCC were not statistically significant for either observer (Az for DWI = 0.818 and 0.864, Az for Gdx MR = 0.902 and 0.842, respectively, p = 0.107 for observer 1 and p = 0.738 for observer 2). The combination of both techniques did not increase the sensitivities of detecting HCC in either observer. When lesions smaller than 2 cm were considered, the DWI set yielded a significantly lower sensitivity as compared with either the Gdx set alone or the combination set. Conclusion: Gadoxetic acid-enhanced MRI was better than DWI for detection the HCC by using 3 T MRI. The combination of DWI and Gdx MRI did not contribute to the successful detection of HCC. years) were included in this study. 49 patients had solitary lesions, 13 had two lesions, and three had three lesions. 51 patients had hepatitis B-related cirrhosis, 5 had hepatitis C-related cirrhosis, 2 had alcoholic cirrhosis, and the remaining 7 had no known underlying diseases. A total of 84 HCCs were identified in these 65 patients. A diagnosis of HCC was based on surgical findings (n = 31), percutaneous biopsy (n = 5), a typical clinical history and tumor marker levels in combination with lipiodol uptakes after TACE or the progressions of the disease as depicted on follow-up CT or MRI obtained at least one year after the initial imaging (n = 30).
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Magnetic Resonance Imaging
All MRI examinations were performed using a 3 T imaging system (MAGNETOM Tim Trio, Siemens Healthcare sector, Erlangen, Germany), equipped with a phased-array coil (MAG-NETOM Tim Trio, Siemens, Erlangen, Germany). We did not use any anti-peristaltic agents or oral contrast agents.
The MRI protocol consisted of a breath-hold transverse T1- MRI improves the detection of HCC (4, 10, 11, 14) . Furthermore, hepatobiliary phase imaging assists in surgical planning (14) .
Recently, diffusion-weighted imaging (DWI) has been applied to liver MRI. DWI is sensitive to the molecular diffusion of water in biological tissues, and recent technological advancements in MRI have enabled the production of high quality DWI images on the liver. DWI is therefore often incorporated into routine liver MRI. It has been reported that DWI improves the accuracy of detection of hepatic metastases as compared to that of superparamagnetic iron-oxide (SPIO)-enhanced MRI (15) .
Moreover, higher signal to noise ratio at 3 T allows the use of higher b values, which are more sensitive to diffusion and less sensitive to transverse relaxation time (T2) and perfusion-related motion (16) (17) (18) . However, the magnetic field inhomogeneities that degrade diffusion-weighted images are exacerbated at 3 T (19) (20) (21) . It is important to assess the diagnostic value of DWI for the detection of HCC in a high field system because 3 T MRI is widely used for routine liver imaging (19, 20) . To our knowledge, there has been no literature comparing the diagnostic performances of DWI and gadoxetic acid-enhanced MR imaging for the detection of HCC in the 3 T system. Therefore, the purpose of this study is to compare DWI, gadoxetic acid-enhanced MRI, and a combination of both techniques for the detection of HCC at 3 T.
MATERIALS AND METHODS
Patients
This study was approved by our institutional review board, and informed consent was not required due to its retrospective 
RESULTS
The areas under the ROC curve (Az) for each observer's abilisystem (Sonic shot 50, Nemoto Kyorindo Co., Ltd., Tokyo, Japan) was used. The actual pulse sequence started manually when the fluoroscopic sequence revealed that the contrast material bolus had reached the abdominal aorta. Of a total of 84 HCCs, observer 1 detected 71 lesions using Gdx MRI (85%) and 57 lesions were detected on DWI (68%), whereas observer 2 noted 75 lesions using Gdx MR imaging (89%) and 64 lesions using DWI (76%) (Fig. 1) . Thirty-six lesions were located in the subphrenic (n = 30) or subcardiac area (n = 6), with 48 lesions located elsewhere. The sensitivities of detection of HCCs in the two image sets for the two observers are shown in Table 2 . Overall, the sensitivities in the Gdx set (mean of 73 lesions detected) were significantly higher than those in the DWI set (mean of 60.5 lesions detected) (p = 0.0004 for ob- Note.-Data are numbers of correct diagnoses; numbers in parentheses are percentages. *When lesions smaller than 2 cm were considered, the DWI set yielded a significantly lower sensitivity compared with those of either the Gdx set alone or the combination set (p = 0.0186, 0.0001 for observer 1, and p = 0.0005, 0.008 for observer 2, respectively). The sensitivity of observer 2 was not statistically significant for lesions larger than or equal to 2 cm (p = 0.1731). Combined set = unenhanced, gadolinium-enhanced dynamic and hepatobiliary phase images, and diffusion-weighted images, DWI set = unenhanced, diffusion-weighted images, Gdx set = unenhanced, gadolinium-enhanced dynamic and hepatobiliary phase images, HCC = hepatocellular carcinoma jksronline.org and combined set were attributed to presumed dysplastic nodules (Fig. 3) .
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DISCUSSION
This study found that gadoxetic acid-enhanced dynamic and hepatobiliary phase MRI is more sensitive for detecting HCC than the DWI when using 3 T MRI. Additions of DWI to gadoxetic acid-enhanced dynamic and hepatobiliary phase MRI did not increase the diagnostic performances for HCC detections. It has been indicated that detection and precise localization of HCC are known to be difficult with DWI alone because of its poor anatomic capabilities (24) (25) (26) . Moreover, DWI has lower resolutions than hepatobiliary phase MRI and may lead to in Table 3 . For observer 2, specificity with DWI set was higher than Gdx set, while for observer 1, specificity with DWI set was lower than Gdx set. There were no significant differences among the mean positive predictive values and negative predictive values for the three image sets.
Eight lesions in 29 patients, which were confirmed via histopathological exam or imaging follow-up, but were not detected with a high confidence score of 4 or 5 by either observers on any image set, and were thus deemed false-negative lesions. In the Gdx lesion set, 14 lesions in 12 patients were not detected with high confidence by either of the observers. For the DWI set, 31 lesions in 27 patients were not detected with high confidence by either of the observers. All lesions detected in the DWI set were also seen in the Gdx set. Eight lesions (0.7-2.3 cm in size) were not noted in the DWI set, but were visualized in the Gdx set.
The rates of false-positive reports for all lesions were 6.1% (6 of 98) for observer 1 and 7.1% (7 of 98) for observer 2, with a mean false positive rate of 2.5% (5 of 196) for Gdx set, 1.5% (3 of 196) for DWI set, and 4.5% (9 of 196) for combined set. In the Gdx Therefore, the subcardiac or subphrenic signal loss may significantly decrease the sensitivity for the detection of HCC in the left lobe or the hepatic dome. Our study results suggest that the degradation of DWI at 3 T outweighs the benefit of using DWI.
Optimization of DWI at 3 T remains a work in progression, and future technical advancements could aid to overcome the low specificity and image quality of DWI.
Although DWI has been incorporated into the routine liver MRI protocol, it may not be helpful for diagnosis and characterization of HCC. DWI has been reported to be an unreliable predictor of local HCC recurrence after transarterial chemoembolization as compared to gadolinium-enhanced MRI (34) , and it did not appear to contribute to the detection of HCC with welldifferentiated components (31, 35) . The limited performance of DWI for the detection of HCC is probably due to the cirrhotic or fibrotic background in patients with HCC. The presence of increased connective tissues in the cirrhotic liver is poor in protons and the decrease of blood flow results in restricted diffusions on DWI (18) . Therefore, the lesion-to-liver contrast between the tumors and background liver may not be evident on DWI. Parikh et al. (25) found a sensitivity of 80.5% for HCC detection by DWI. In our study, the sensitivity (76%) was similar to the previous study for HCC detection using DWI, while increased sensitivity (89%) was achieved with dynamic and hepatobiliary phase imaging.
A hepatobiliary contrast agent provides both a dynamic and poor depictions of small focal hepatic lesions (26) . All lesions detected on DWI were also seen on dynamic and hepatobiliary images. Therefore, we believe that DWI may not be helpful for The potential usefulness of DWI for detecting and characterizing focal hepatic lesions including HCCs and metastases has been reported (25) (26) (27) (28) (29) . In addition, combined reading of DWI and T2-weighted images were found to be superior to the SPIOenhanced MRI (25, 26, 30) , and the addition of DWI to conventional diagnostic criteria increased the sensitivity for HCC diagnosis (23) . However, it is important to emphasize that most studies which evaluate the usefulness of DWI in the diagnosis of hepatic tumors use 1.5 T MRI scanners (23, 31, 32) . Recently, 3
T MRI imaging is widely used in clinical practices because it allows high spatial and temporal resolution by increasing the signal-to-noise ratios. Higher b values are used for 3 T MRI, resulting in increased sensitivity to diffusions and less sensitivity to transverse relaxation time (T2) and perfusion-related motion (33) . Therefore, 3 T scanners with DWI are widely used for routine liver MRI. Unfortunately, the magnetic field inhomogeneities that degrade DWI are increased with 3 T (19-21). Two im- . Three-dimensional GRE MRI using a hepatobiliary contrast agent provides thin sections with no gaps, high signal-to-noise ratio, and high sensitivity for detecting sub-centimeter-sized hepatocellular lesions (5, (36) (37) (38) .
Three-dimensional GRE MRI also avoids the respiratory or susceptibility artifacts that are a problem in DWI. Therefore, gadoxetic acid-enhanced MRI appears to be better than DWI for the diagnosis of HCC when considering both diagnostic performances and image qualities of 3 T MRI.
Our results suggest that the addition of DWI to dynamic and hepatobiliary phase imaging may not be helpful for the detection of HCC. Nishie et al. (31) reported that an SPIO-enhanced MRI + DWI set outperformed the SPIO-enhanced set in HCC depiction when using a 1.5 T scanner. The average area under the ROC curve (Az) of the SPIO-enhanced MRI + DWI set (Az = 0.870) was significantly higher than that of SPIO-enhanced set (Az = 0.820) for detecting HCC. In our study, the combined interpretation of both DWI and gadoxetic acid-enhanced MRI did not increase the diagnostic performances of HCC detection.
It has been reported that DWI may not contribute to the detections of HCC with well-differentiated components (27, 31) .
However, the gadoxetic acid-enhanced hepatobiliary phase of MR imaging has been reported to be useful for preoperative diagnosis of early HCC in a preliminary report (14) . Therefore, gadoxetic acid-enhanced MRI appears to be more beneficial than DWI for depicting HCC. Cirrhotic patients with suspected HCC and impaired hepatobiliary enhancement due to decreased hepatic functions may benefit from DWI because it can detect HCCs in the absence of contrast materials (27) . DWI can also be used for screening patients for hepatocellular lesions, by reducing the number of overlooked lesions.
HCC size is an important prognostic factor for patient surviv- 
